Regenxbio SG&A Expense (TTM) Analysis

Regenxbio Inc (RGNX)

10.88 +0.06 (+0.60%) USD | NASDAQ | Jul 05, 16:00

10.88 0.00 (0.00%) After-Hours: 16:35

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	84.15M
December 31, 2023	88.49M
September 30, 2023	90.62M
June 30, 2023	88.46M
March 31, 2023	85.60M
December 31, 2022	85.28M
September 30, 2022	86.11M
June 30, 2022	86.22M
March 31, 2022	83.81M
December 31, 2021	79.33M
September 30, 2021	74.86M
June 30, 2021	69.69M
March 31, 2021	66.82M
December 31, 2020	63.82M
September 30, 2020	60.70M
June 30, 2020	57.24M
March 31, 2020	55.09M
December 31, 2019	51.82M

Date	Value
September 30, 2019	48.51M
June 30, 2019	45.12M
March 31, 2019	40.03M
December 31, 2018	36.85M
September 30, 2018	30.51M
June 30, 2018	30.95M
March 31, 2018	28.99M
December 31, 2017	27.23M
September 30, 2017	28.16M
June 30, 2017	24.92M
March 31, 2017	24.73M
December 31, 2016	23.59M
September 30, 2016	22.09M
June 30, 2016	18.46M
March 31, 2016	15.68M
December 31, 2015	11.92M
September 30, 2015	8.799M
June 30, 2015	7.302M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

48.51M

Minimum

Sep 2019

90.62M

Maximum

Sep 2023

74.03M

Average

79.33M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks